Taiwanese MS and NMOSD patients exhibit distinct cardiovascular phenotypes. MS is characterized by a "lipid paradox" where dyslipidemia, though less prevalent, serves as a high-potency risk trigger. In NMOSD, cardiovascular risk is treatment-related and masked by high medication burden. Comprehensive risk assessment must prioritize these specific metabolic and iatrogenic factors.
Tsai et al. (Wed,) studied this question.